Notice of Allowance for patent application. Yesterday, Baudax Bio announced the US Patent and Trademark Office (USPTO) provided a Notice of Allowance for patent application No. 16/297095 (the '095 application). The USPTO typically issues a Notice after determining the patent application should be granted.The Patent should be granted in the next few months. The patent application covers the multiple doses of ANJESO for the treatment of moderate to severe pain, and a reduction in use of rescue analgesics 48 hours following the first dose. The patent from the '095 titled application "Methods of administering intravenous meloxicam in a bolus dose", once issued, will be eligible for listing in the FDA's Orange Book. Read More >>